Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1

Status

Recruiting 5Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Interventional 7

Sponsor

Cancer Type

CNS 4Tumor-Agnostic 2Gastrointestinal 2Sarcoma 1Genitourinary 1

Conditions

Glioblastoma 37Glioma 19Brain Neoplasms 12Gliosarcoma 10Astrocytoma 10Neuroblastoma 9Sarcoma, Ewing 8Rhabdomyosarcoma 7Neoplasms 7Recurrence 6Sarcoma 5Oligodendroglioma 5Small Cell Lung Carcinoma 3Osteosarcoma 3Neoplasm Metastasis 3Medulloblastoma 3Diffuse Intrinsic Pontine Glioma 3Wilms Tumor 2Pancreatic Neoplasms 2Melanoma 2Lymphoma, Follicular 2Hepatoblastoma 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Spinal Cord Neoplasms 1Somatostatinoma 1Rhabdoid Tumor 1Refractory Solid Tumors 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1

Interventions

pembrolizumab 38Bevacizumab 23Cyclophosphamide 22Standard of Care 18Blood Specimen Collection 17Carboplatin 16Paclitaxel 15Nivolumab 14Gemcitabine 14Pemetrexed 13Exercise 13Cisplatin 12atezolizumab 11Radiotherapy 11Fluorouracil 11Doxorubicin 11Surveys and Questionnaires 9Rituximab 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Cetuximab 9Biopsy 9130-nm albumin-bound paclitaxel 9durvalumab 8abemaciclib 8Docetaxel 8olaparib 7Temozolomide 7Prednisone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Neoplasms × Temozolomide × 90 days × Clear all
NCT03899155 2026-05-27

Pan Tumor Rollover Study

Bristol-Myers Squibb

Phase 2 Recruiting
1,500 enrolled
Tumor-Agnostic

Neoplasms

NCT06413706 2026-05-22

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Eli Lilly and Company

Phase 2 Active not recruiting
45 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT04984733 2026-05-18

ELEVATE

University of Southampton

Phase 2 Completed
13 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT07195591 2026-04-30

BRIDGES

GT Medical Technologies, Inc.

Phase 3 Recruiting
766 enrolled
CNS

Glioblastoma, Neoplasms

NCT06012695 2026-04-29

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

Novelwise Pharmaceutical Corporation

Phase 1/2 Recruiting
79 enrolled
CNS

Brain Neoplasms, Neoplasms

NCT05999994 2026-03-27

CAMPFIRE

Eli Lilly and Company

Phase 2 Recruiting
105 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡